Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Other financing activities (2019 - 2024)

Cardiff Oncology's Other financing activities history spans 6 years, with the latest figure at $197000.0 for Q2 2024.

  • For Q2 2024, Other financing activities changed N/A year-over-year to $197000.0; the TTM value through Jun 2024 reached $997000.0, changed N/A, while the annual FY2020 figure was -$8000.0, 80.0% up from the prior year.
  • Other financing activities for Q2 2024 was $197000.0 at Cardiff Oncology, down from $800000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $800000.0 in Q2 2021 and bottomed at $197000.0 in Q2 2024.